Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Non-Current Debt (2016)

Corcept Therapeutics (CORT) has disclosed Non-Current Debt for 5 consecutive years, with $3.7 million as the latest value for Q2 2016.

  • For Q2 2016, Non-Current Debt fell 80.7% year-over-year to $3.7 million; the TTM value through Jun 2016 reached $3.7 million, down 80.7%, while the annual FY2015 figure was $12.5 million, 48.79% down from the prior year.
  • Non-Current Debt hit $3.7 million in Q2 2016 for Corcept Therapeutics, down from $8.7 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $30.2 million in Q2 2013 and bottomed at $3.7 million in Q2 2016.
  • Average Non-Current Debt over 5 years is $22.8 million, with a median of $26.8 million recorded in 2014.
  • Year-over-year, Non-Current Debt grew 6.41% in 2013 and then plummeted 80.7% in 2016.
  • Corcept Therapeutics' Non-Current Debt stood at $29.0 million in 2012, then grew by 1.01% to $29.3 million in 2013, then fell by 16.57% to $24.5 million in 2014, then tumbled by 48.79% to $12.5 million in 2015, then crashed by 70.11% to $3.7 million in 2016.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $3.7 million, $8.7 million, and $12.5 million for Q2 2016, Q1 2016, and Q4 2015 respectively.